PS150 Total Knee Arthroplasty Outcomes Registry
Outcomes of Total Knee Arthroplasty (TKA) Using the Sigma PS150 Primary Total Knee System
1 other identifier
observational
175
2 countries
4
Brief Summary
This registry is intended to evaluate the clinical outcomes of the DePuy P.F.C. Sigma PS150 RP Total Knee System. 200 participants will be enrolled prospectively or retrospectively and the follow up period will be 5 years. Data collection will include Radiographic Analysis, Knee Society Evaluation and Adverse Events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2015
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2014
CompletedFirst Posted
Study publicly available on registry
December 18, 2014
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2021
CompletedFebruary 22, 2023
February 1, 2023
6.8 years
December 15, 2014
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Implant Survivorship
Lack of revision with revision meaning no removal or replacement of any TKA component.
5 years
Secondary Outcomes (7)
Knee Society Score - Knee Score
1, 3 & 5 years
Knee Society Score - Function
1, 3 & 5 years
Pain sub-question of the Knee Society Score
1, 3 & 5 years
Flexion
1, 3 & 5 years
Extension
1, 3 & 5 years
- +2 more secondary outcomes
Study Arms (1)
Participants
P.F.C. Sigma PS150 RP Total Knee System
Interventions
Total Knee Arthroplasty - surgical procedure to replace knee with metal implant
Eligibility Criteria
Patients may be considered for inclusion in the registry if they meet the inclusion criteria below.
You may qualify if:
- Primary total knee replacement for any indication in accordance with the Instructions For Use accompanying the SIGMA PS150 implant.
- Signed Informed Patient Consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Greenslopes Private Hospital
Greenslopes, Australia
Northern Orthopaedics
Sydney, Australia
Gachon University Gil Medical Center
Incheon, 405-760, South Korea
Jeju National University Hospital
Jeju City, 690-767, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Dekkers, MBBS
Greenslopes Private Hospital, Brisbane
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 5 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2014
First Posted
December 18, 2014
Study Start
February 1, 2015
Primary Completion
November 3, 2021
Study Completion
November 3, 2021
Last Updated
February 22, 2023
Record last verified: 2023-02